AparnaGoelMD
Gastroenterology • Palo Alto, CAHepatology & Liver Transplantation
Fellow, Mount Sinai Icahn School of Medicine, New York
Dr. Goel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-498-7878
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2013 - 2016
University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026
NY State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. Start of enrollment: 2023 May 10
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.Mitchell Shiffman, Ben Da, Aparna Goel, Allison Kwong, Lance Stein
NEJM Evidence. 2025-02-01 - Statin use is associated with protection against acute cholangitis in patients with primary sclerosing cholangitis: a multi-center retrospective cohort study.Chiraag Kulkarni, George Cholankeril, Touran Fardeen, Joseph Rathkey, Samir Khan
Clinical and Translational Gastroenterology. 2025-01-21 - 1 citationsPortal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study.Kelly Hu, Mai Sedki, Allison Kwong, Andrew Kesselman, Kanti Pallav Kolli
Alimentary Pharmacology & Therapeutics. 2025-01-01
Press Mentions
Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025February 18th, 2025- Screening Options for Rare MalignanciesNovember 1st, 2024
- Autoimmune Liver Disease Forum to Examine Solutions for Improving Health OutcomesMarch 14th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
